These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 11458759)

  • 41. What are the benefits of extended dissection of the regional renal lymph nodes in the therapy of renal cell carcinoma.
    Herrlinger A; Schrott KM; Schott G; Sigel A
    J Urol; 1991 Nov; 146(5):1224-7. PubMed ID: 1942267
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Lymphatic metastases in renal cell carcinoma. What is the value of operation and adjuvant therapy?].
    Mickisch GH
    Urologe A; 1999 Jul; 38(4):326-31. PubMed ID: 10444789
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lymph node dissection during radical nephrectomy: A Canadian multi-institutional analysis.
    Kokorovic A; Breau RH; Kapoor A; Finelli A; So AI; Lavallee LT; Tanguay S; Pouliot F; Drachenberg DE; Fairey A; Lattouf JB; Kawakami J; Wood L; Mallick R; Rendon RA
    Urol Oncol; 2021 Jun; 39(6):371.e17-371.e25. PubMed ID: 33785219
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lymph node dissection at the time of radical nephrectomy for high-risk clear cell renal cell carcinoma: indications and recommendations for surgical templates.
    Crispen PL; Breau RH; Allmer C; Lohse CM; Cheville JC; Leibovich BC; Blute ML
    Eur Urol; 2011 Jan; 59(1):18-23. PubMed ID: 20933322
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Partial nephrectomy for renal masses ≥ 7 cm: technical, oncological and functional outcomes.
    Long CJ; Canter DJ; Kutikov A; Li T; Simhan J; Smaldone M; Teper E; Viterbo R; Boorjian SA; Chen DY; Greenberg RE; Uzzo RG
    BJU Int; 2012 May; 109(10):1450-6. PubMed ID: 22221502
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Radical surgery for renal-cell carcinoma: caval neoplastic excision, adrenalectomy, lymphadenectomy, adjacent organ resection.
    Marshall FF; Steinberg GD; Pound CR; Partin AW
    World J Urol; 1995; 13(3):159-62. PubMed ID: 7550387
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Systematic lymph node dissection in lung metastasectomy of renal cell carcinoma: an 18 years of experience.
    Renaud S; Falcoz PE; Alifano M; Olland A; Magdeleinat P; Pagès O; Regnard JF; Massard G
    J Surg Oncol; 2014 Jun; 109(8):823-9. PubMed ID: 24619772
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Lymphadenectomy for renal cell carcinoma].
    Masuda F; Ohnishi T; Nakada J; Suzuki M; Mori Y; Iizuka N; Machida T
    Hinyokika Kiyo; 1985 Apr; 31(4):595-600. PubMed ID: 4036736
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Tumor size and regional lymph node metastasis in patients with M0 renal cell carcinoma: analysis in those having regional lymph node dissection].
    Hashimoto K; Hisasue S; Yanase M; Takahashi A; Hisataki T; Kitamura H; Masumori N; Itoh N; Tsukamoto T
    Hinyokika Kiyo; 2005 Sep; 51(9):621-5. PubMed ID: 16229376
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Renal cell carcinoma with renal vein and inferior vena caval involvement: clinicopathological features, surgical techniques and outcomes.
    Parekh DJ; Cookson MS; Chapman W; Harrell F; Wells N; Chang SS; Smith JA
    J Urol; 2005 Jun; 173(6):1897-902. PubMed ID: 15879771
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Radical nephrectomy with and without lymph node dissection: preliminary results of the EORTC randomized phase III protocol 30881. EORTC Genitourinary Group.
    Blom JH; van Poppel H; Marechal JM; Jacqmin D; Sylvester R; Schröder FH; de Prijck L
    Eur Urol; 1999 Dec; 36(6):570-5. PubMed ID: 10559610
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Kidney size and cancer-specific survival for patients undergoing nephrectomy for pT1 clear cell renal cell carcinoma.
    Jorns JJ; Thiel DD; Lohse C; Williams A; Arnold M; Cheville J; Leibovich B; Parker AS
    Urology; 2012 Jul; 80(1):147-50. PubMed ID: 22748870
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long-term survival after radical surgery for renal cell carcinoma with tumour thrombus extension into the right atrium.
    Dominik J; Moravek P; Zacek P; Vojacek J; Brtko M; Podhola M; Pacovsky J; Harrer J
    BJU Int; 2013 Mar; 111(3 Pt B):E59-64. PubMed ID: 22984824
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The role of lymphadenectomy in renal cancer surgery. An update.
    Giannakopoulos X; Charalabopoulos K; Charalabopoulos A; Golias C; Baltogiannis D; Sofikitis N
    Exp Oncol; 2004 Dec; 26(4):261-4. PubMed ID: 15627056
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prognostic significance of lymph node invasion in patients with metastatic renal cell carcinoma: a population-based perspective.
    Lughezzani G; Capitanio U; Jeldres C; Isbarn H; Shariat SF; Arjane P; Widmer H; Perrotte P; Montorsi F; Karakiewicz PI
    Cancer; 2009 Dec; 115(24):5680-7. PubMed ID: 19824083
    [TBL] [Abstract][Full Text] [Related]  

  • 56. pT1 clear cell renal cell carcinoma: a study of the association between MIB-1 proliferative activity and pathologic features and cancer specific survival.
    Cheville JC; Zincke H; Lohse CM; Sebo TJ; Riehle D; Weaver AL; Blute ML
    Cancer; 2002 Apr; 94(8):2180-4. PubMed ID: 12001115
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Re: Extent of lymph node dissection at nephrectomy affects cancer-specific survival and metastatic progression in specific sub-categories of patients with renal cell carcinoma (RCC).
    Laguna MP
    J Urol; 2015 Feb; 193(2):457. PubMed ID: 25617268
    [No Abstract]   [Full Text] [Related]  

  • 58. Survival after partial and radical nephrectomy for the treatment of stage T1bN0M0 renal cell carcinoma (RCC) in the USA: a propensity scoring approach.
    Badalato GM; Kates M; Wisnivesky JP; Choudhury AR; McKiernan JM
    BJU Int; 2012 May; 109(10):1457-62. PubMed ID: 21933334
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Renal cell carcinoma: surgical management of regional lymph nodes and inferior vena-caval tumor thrombus.
    Marshall FF
    Semin Surg Oncol; 1988; 4(2):129-32. PubMed ID: 3293154
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Three-dimensional tumour volume and cancer-specific survival for patients undergoing nephrectomy to treat pT1 clear-cell renal cell carcinoma.
    Jorns J; Thiel DD; Lohse CM; Williams A; Arnold ML; Cheville JC; Leibovich BC; Parker AS
    BJU Int; 2012 Oct; 110(7):956-60. PubMed ID: 22300498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.